Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.09 from other evidence | 0.00 |
| cell type Human Protein Atlas | group enriched outside the brain (proximal tubule cells) | 0.10 |
| chemistry Open Targets | reachable by antibody | 0.36 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 3 Parkinson's papers of 231 | 0.82 |
| pathways Reactome | 2 pathways; mostly protein handling | 0.90 |
No case: the score is under the bar. Receipt 2885
Sealed predictions
- NAGLU in dopamine neurons, braak+0.31 (p 0.414) → -0.49 (p 0.181)receipt 2892
Swarm cases
receipt 2892: NAGLU in dopamine neurons, braak
- power
- full sample -0.06 (p 0.827, n 18), 95% CI -0.51 to +0.42. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.06 (p 0.827, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.06 (p 0.800, n 18). could be the mix.
- skeptic
- leave-one-out range -0.20 to +0.08, sign flips 4; without severely affected donors -0.06 (p 0.827, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for NAGLU in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts